Ames MM - Search Results

1

SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen.

Moyer AM, Suman VJ, Weinshilboum RM, Avula R, Black JL, Safgren SL, Kuffel MJ, Ames MM, Ingle JN, Goetz MP. Moyer AM, et al. Among authors: ames mm. Pharmacogenomics. 2011 Nov;12(11):1535-43. doi: 10.2217/pgs.11.97. Epub 2011 Oct 3. Pharmacogenomics. 2011. PMID: 21961651 Free PMC article.

2

Human and rat liver phenol sulfotransferase: structure-activity relationships for phenolic substrates.

Campbell NR, Van Loon JA, Sundaram RS, Ames MM, Hansch C, Weinshilboum R. Campbell NR, et al. Among authors: ames mm. Mol Pharmacol. 1987 Dec;32(6):813-9. Mol Pharmacol. 1987. PMID: 3480422

3

Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1/1A2.

Kuffel MJ, Schroeder JC, Pobst LJ, Naylor S, Reid JM, Kaufmann SH, Ames MM. Kuffel MJ, et al. Among authors: ames mm. Mol Pharmacol. 2002 Jul;62(1):143-53. doi: 10.1124/mol.62.1.143. Mol Pharmacol. 2002. PMID: 12065765

4

Rat and human liver cytochrome P-450 isoform metabolism of ecteinascidin 743 does not predict gender-dependent toxicity in humans.

Reid JM, Kuffel MJ, Ruben SL, Morales JJ, Rinehart KL, Squillace DP, Ames MM. Reid JM, et al. Among authors: ames mm. Clin Cancer Res. 2002 Sep;8(9):2952-62. Clin Cancer Res. 2002. PMID: 12231541

5

Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors.

Goetz MP, Erlichman C, Windebank AJ, Reid JM, Sloan JA, Atherton P, Adjei AA, Rubin J, Pitot H, Galanis E, Ames MM, Goldberg RM. Goetz MP, et al. Among authors: ames mm. J Clin Oncol. 2003 Oct 15;21(20):3761-9. doi: 10.1200/JCO.2003.01.238. Epub 2003 Sep 8. J Clin Oncol. 2003. PMID: 12963697 Clinical Trial.

6

Primer on medical genomics. Part XII: Pharmacogenomics--general principles with cancer as a model.

Goetz MP, Ames MM, Weinshilboum RM. Goetz MP, et al. Among authors: ames mm. Mayo Clin Proc. 2004 Mar;79(3):376-84. doi: 10.4065/79.3.376. Mayo Clin Proc. 2004. PMID: 15008610 Review.

7

Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors.

Reid JM, Qu W, Safgren SL, Ames MM, Krailo MD, Seibel NL, Kuttesch J, Holcenberg J. Reid JM, et al. Among authors: ames mm. J Clin Oncol. 2004 Jun 15;22(12):2445-51. doi: 10.1200/JCO.2004.10.142. J Clin Oncol. 2004. PMID: 15197207 Clinical Trial.

8

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.

Goetz MP, Toft D, Reid J, Ames M, Stensgard B, Safgren S, Adjei AA, Sloan J, Atherton P, Vasile V, Salazaar S, Adjei A, Croghan G, Erlichman C. Goetz MP, et al. J Clin Oncol. 2005 Feb 20;23(6):1078-87. doi: 10.1200/JCO.2005.09.119. J Clin Oncol. 2005. PMID: 15718306 Clinical Trial.

9

Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial.

Galanis E, Buckner JC, Maurer MJ, Reid JM, Kuffel MJ, Ames MM, Scheithauer BW, Hammack JE, Pipoly G, Kuross SA. Galanis E, et al. Among authors: ames mm. Invest New Drugs. 2005 Oct;23(5):495-503. doi: 10.1007/s10637-005-2910-4. Invest New Drugs. 2005. PMID: 16133802 Clinical Trial.

10

Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia.

Kaufmann SH, Karp JE, Letendre L, Kottke TJ, Safgren S, Greer J, Gojo I, Atherton P, Svingen PA, Loegering DA, Litzow MR, Sloan JA, Reid JM, Ames MM, Adjei AA, Erlichman C. Kaufmann SH, et al. Among authors: ames mm. Clin Cancer Res. 2005 Sep 15;11(18):6641-9. doi: 10.1158/1078-0432.CCR-05-0817. Clin Cancer Res. 2005. PMID: 16166443 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page